Tang Capital Management LLC Viking Therapeutics, Inc. Transaction History
Tang Capital Management LLC
- $819 Million
- Q2 2024
A detailed history of Tang Capital Management LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 120,000 shares of VKTX stock, worth $7.6 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
120,000
Previous 100,000
20.0%
Holding current value
$7.6 Million
Previous $8.2 Million
22.43%
% of portfolio
0.78%
Previous 1.0%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
442Shares Held
63.3MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$639 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$382 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$324 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$143 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$118 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.86B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...